In this study, we enrolled 1201 patients from four independent GEO datasets and investigated the potential prognostic role of FSCN family in MM by exploring the relationships between FSCN1-3 expression profiles and the clinical outcomes of MM patients. This evidence concerns the gene FSCN1 and Miyoshi myopathy.